Dr. Reddy’s Laboratories Ltd. a global pharmaceutical company, today announced the launch of its generic Semaglutide Injection in Canada.

Dr. Reddy’s Laboratories Limited RDY on Friday launched its generic Semaglutide Injection in Canada. This move is significant ...

Dr Reddy's Laboratories has introduced its generic Semaglutide injection for type 2 diabetes treatment in Canada. The launch ...

Dr. Reddy’s Laboratories Ltd. announced that it has received a Notice of Compliance (NOC) from Health Canada for its generic Semaglutide Injection.

Dr Reddy’s Laboratories Ltd. plans to launch its version of generic Ozempic this month, filling a void in the Canadian market ...

Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the ...

Dr. Reddy’s launches generic Semaglutide Injection in Canada, marking the first G7 approval for this diabetes treatment.

Dr. Reddy’s Laboratories has received a Notice of Compliance (NOC)from Health Canada for its generic Semaglutide injection.

Dr Reddy's said it is among the first to introduce a generic semaglutide injection in the Canadian market after it received ...

The launch comes as global demand for such therapies continues to surge, driven by rising diabetes prevalence and growing use ...